Complement factor H gene polymorphisms and Chlamydia pneumoniae infection in age-related macular degeneration

Eye

Volumn 23, Issue 12, 2009, Pages 2228-2232

  Haas, P ^a   Steindl, K ^a   Schmid Kubista, K E ^a   Aggermann, T ^a   Krugluger, W ^a   Hageman, G S ^b   Binder, S ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Aetiology; Age related macular degeneration; Chlamydia pneumoniae; Complement factor H; Infection; Polymorphism

Indexed keywords

COMPLEMENT FACTOR H; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR;

AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; AUSTRIA; CASE-CONTROL STUDIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COMPLEMENT FACTOR H; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOGLOBULIN G; LOGISTIC MODELS; MACULAR DEGENERATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 71649095901     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.422     Document Type: Article

References (31)

1. Ambatti J. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003; 48: 257-293.
2. Spaide RF, Armstrong D, Browne R. Continuing medical education review: choroidal neovascularisation in age-related macular degenerationFwhat is the cause? Retina 2003; 2003: 595-614.
3. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385-389.
4. Edwards AO, Ritter III R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308: 421-424.
5. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308: 419-421.
6. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005; 102: 7227-7232.
7. Zareparsi S, Branham KE, Li M, Shah S, Klein RJ, Ott J et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 2005; 77: 149-153.
8. Magnusson KP, Duan S, Sigurdsson H, Petursson H, Yang Z, Zhao Y et al. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med 2006; 3: e5.
9. Sepp T, Khan JC, Thurlby DA, Shahid H, Clayton DG, Moore AT et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci 2006; 47: 536-540.
10. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger Tet al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005; 14: 3227-3236.
11. Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997; 277: 1805-1807.
12. Klaver CC, Kliffen M, Van Duijn CM, Hofman A, Cruts M, Grobbee De et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998; 63: 200-206. Erratum in: Am J Hum Genet 1998; 63:1252.
13. Stone EM, Braun TA, Russell SR, Kuehn MH, Lotery AJ, Moore PA et al. Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med 2004; 351: 346-353.
14. Conley YP, Thalamuthu A, Jakobsdottir J,Weeks DE, Mah T, Ferrell RE et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum Mol Genet 2005; 14: 1991-2002.
15. Zareparsi S, Buraczynska M, Branham KE, Shah S, Eng D, Li M et al. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet 2005; 14: 1449-1455. (Pubitemid 40834203)
16. Spencer KL, Hauser MA, Olson LM, Schmidt S, Scott WK, Gallins P et al. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet 2007; 16(16): 1986-1992. (Pubitemid 47354881)
17. Miller DM, Espinosa-Heidmann DG, Legra J, Dubovy SR, Sner IJ, Sedmak DD et al. The association of prior cytomegalovirus infection with neovascular agerelatedvmacular degeneration. Am J Ophthalmol 2004; 138(3): 323-328.
18. Kijlstra A, La Heij E, Hendrikse F. Immunological factors in the pathogenesis and treatment of age-related macular degeneration. Ocul Immunol Inflamm 2005; 13(1): 3-11.
19. Kuo CC, Jackson LA, Campbell LA, Greystone JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995; 8: 451-461.
20. Verkooyen R, Willemse D, Hier-Van Casteren S, Joulandan SA, Snijder RJ, Van den Bosch JM et al. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections. J Clin Microbiol 1998; 36: 2301-2307.
21. Robman L, Mahdi OS, Wang JJ, Burlutsky G, Mitchell P, Byrne G et al. Exposure to Chlamydia pneumoniae infection and age-related macular degeneration: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci 2007; 48(9): 4007-4011. (Pubitemid 351261022)
22. Guymer R, Robman L. Chlamydia pneumoniae and age-related macular degeneration: a role in pathogenesis or merely a chance association? Clin Experiment Ophthalmol 2007; 35(1): 89-93.
23. Kessler W, Jantos CA, Dreier J, Pavlovic S. Chlamydia pneumoniae is not detectable in subretinal neovascular membranes in the exudative stage of age-related macular degeneration. Acta Ophthalmol Scand 2006; 84(3): 333-337.
24. KalayogluMV, Bula D, Arroyo J, Gragoudas ES, D'Amico D, Miller JW. Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to agerelated macular degeneration. Graefes Arch Clin Exp Ophthalmol 2005; 243(11): 1080-1090.
25. Robman L, Mahdi O, McCarty C, Dimitrov P, Tikellis G, McNeil J et al. Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration. Am J Epidemiol 2005; 161(11): 1013-1019.
26. Ishida O, Oku H, Ikeda T, Nishimura M, Kawagoe K, Nakamura K. Is Chlamydia pneumoniae infection a risk factor for age-related macular degeneration? Br J Ophthalmol 2003; 87(5): 523-524.
27. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 2001; 132(5): 668-681.
28. Chylack Jr LT, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL et al. The lens opacities classification system III. The longitudinal study of Cataract study group. Arch Ophthalmol 1993; 111(6): 831-836.
29. Wegscheider BJ, Weger M, Renner W, Steinbrugger I, März W, Mossböck G et al. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. Ophthalmology 2007; 114(4): 738-742. (Pubitemid 46483679)
30. Seddon JM, Georg S, Rosner B, Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 2005; 123: 774-782.
31. Kalayoglu MV, GalVan C, Mahdi OS, Byrne GI, Mansour S. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch Ophthalmol 2003; 121(4): 478-482.